English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background: Nonalcoholic fatty liver disease (NAFLD) fibrosis score and BARD score are two of the many noninvasive scoring systems used in the evaluation of the fibrosis in patients with NAFLD biochemically. Ultrasound (USG) is the most common imaging modality for detection of hepatic fibrosis, as it is inexpensive and easily available. Aims: This study attempts to correlate the biochemical and ultrasonographic evidence of fibrosis. It tries to correlate two noninvasive tools for assessing fibrosis in overweight population with NAFLD. Materials and Methods: Prospective study was conducted in which 106 patients participated with BMI; more than 25 underwent ultrasonography for evidence of fatty liver, which was then categorized in three grades, and also scored using biochemical parameters to obtain the NAFLD fibrosis score and BARD score. The scores were then compared with the grades of fatty liver on USG to see for correlation between the two. Results: No statistically significant correlation was found between biochemical evidence of fibrosis and USG evidence of fibrosis in overweight patients of NAFLD. Conclusion: Thus, the biochemical evidence of fibrosis or NAFLD in the form of NAFLD fibrosis score did not correlate with USG evidence of fatty liver. The USG findings of fatty liver may not directly correlate with actual fibrosis in these patients. Context: NAFLD is also an emerging disease in developing countries, which remains silent for years. Noninvasive methods are required for early diagnosis. This study attempts to correlate two noninvasive tools for assessing fibrosis in overweight population of NAFLD. Most of the patients of NAFLD are asymptomatic thus invasive methods are not routinely recommended in them. Thus, it becomes pertinent to study the noninvasive tools extensively for their possible additive use.

international journal of medicine and public health

Correlation of NAFLD fibrosis score and BARD score with ultrasonographic evidence of nonalcoholic fatty liver disease in overweight patients: A prospective study